Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign up Log in
All Resources Treatments A-Z Personal Assistant What is This Site Help Center Crisis
Powered By

Top 2 search results for "Ojjaara" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
What Is a JAK2 Mutation?
... Food and Drug Administration Ojjaara Prescribing Information — GSK A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis (Pacifica) — ClinicalTrials.gov A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Patients (Momentum ...
What Is a JAK2 Mutation?
... Food and Drug Administration Ojjaara Prescribing Information — GSK A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis (Pacifica) — ClinicalTrials.gov A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Patients (Momentum ...
7 Treatment Options for Myeloproliferative Neoplasms
... These medications can also help improve MPN symptoms and reduce the size of your spleen.JAK inhibitors approved to treat myelofibrosis include: Fedratinib (Inrebic) Momelotinib (Ojjaara) Pacritinib (Vonjo) Ruxolitinib (Jakafi) Tyrosine Kinase InhibitorsTKIs can be used to treat chronic myeloid leukemia. ...
7 Treatment Options for Myeloproliferative Neoplasms
... These medications can also help improve MPN symptoms and reduce the size of your spleen.JAK inhibitors approved to treat myelofibrosis include: Fedratinib (Inrebic) Momelotinib (Ojjaara) Pacritinib (Vonjo) Ruxolitinib (Jakafi) Tyrosine Kinase InhibitorsTKIs can be used to treat chronic myeloid leukemia. ...